Clinical pharmacology of isoniazid
Sokolova, G.V.; Ivleva, A.I.; Ziia, A.V.; Zeliger, L.R.; Suvorova, V.I.
Problemy Tuberkuleza 9: 55-60
1984
ISSN/ISBN: 0032-9533 PMID: 6504886 Document Number: 241853
Document emailed within 1 workday
Related Documents
Vyas, B. 2001: European Association of Clinical Pharmacology and Therapeutics--Fifth Congress. Clinical pharmacology: from molecule to society--bridging the gap via Man IDrugs: the investigational drugs journal 4(10): 1133-1137Poulsen, H.Enghusen.; Schmitz, O.E.; Brøsen, K. 2002: Clinical pharmacology 2001--important events. The Danish Society of Clinical Pharmacology Ugeskrift for laeger 164(12): 1652
Duchêne-Marullaz, P. 1977: Pharmacology, clinical pharmacology and therapeutic effects of Royat's thermal gas Semaine des Hopitaux. Therapeutique 53(7-8): 361-362
Königshausen, T.; Altrogge, D.; Hein, D.; Grabensee, B.; Pütter, J. 1978: Isoniazid elimination by means of hemodialysis and hemoperfusion in acute isoniazid poisoning Verhandlungen der Deutschen Gesellschaft für Innere Medizin 84: 1241-1244
Amlabu, V.; Mulligan, C.; Jele, N.; Evans, A.; Gray, D.; Zar, H.J.; McIlleron, H.; Smith, P. 2014: Isoniazid/acetylisoniazid urine concentrations: markers of adherence to isoniazid preventive therapy in children International Journal of Tuberculosis and Lung Disease: the Official Journal of the International Union Against Tuberculosis and Lung Disease 18(5): 528-530
Belianin, I.I. 2004: Decreased resistance of multiresistant mycobacteria to isoniazid during the treatment of experimental tuberculosis with ozone and isoniazid Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 2004(3): 95-98
Mthiyane, T.; Millard, J.; Adamson, J.; Balakrishna, Y.; Connolly, C.; Owen, A.; Rustomjee, R.; Dheda, K.; McIlleron, H.; Pym, A.S. 2020: N-Acetyltransferase 2 Genotypes among Zulu-Speaking South Africans and Isoniazid and N-Acetyl-Isoniazid Pharmacokinetics during Antituberculosis Treatment Antimicrobial Agents and ChemoTherapy 64(4)
Kucharz, E.J. 1995: Studies on immunomodulatory properties of isoniazid. Influence of isoniazid on responsiveness of peripheral blood mononuclear cells to interleukin-2 Central European Journal of Public Health 3(2): 65-66
Moore, T.C. 1971: Effective use of isoniazid and an antihistamine in clinical renal transplantation Surgery Gynecology and Obstetrics 133(1): 75-80
Demchenko, V.T.; Kantariia, V.A.; Kerimov, B.L.; Shogentsukova, E.A.; Shomakhova, N.S. 1984: Clinical pharmacology and clinical pharmacy in a general clinical hospital Sovetskoe Zdravookhranenie 9: 27-29
Perry, T.L.; Wright, J.M.; Hansen, S.; Thomas, S.M.; Allan, B.M.; Baird, P.A.; Diewold, P.A. 1982: A double-blind clinical trial of isoniazid in Huntington disease Neurology 32(4): 354-358
Moiseev, V.S.; Lepakhin, V.K. 1989: Clinical pharmacology and problems of drug therapy in the clinical picture of internal diseases Terapevticheskii Arkhiv 61(8): 6-10
Simić, D.; Vrhovac, B. 1978: Clinical pharmacology: its importance, place, and role in larger clinical centers Medicinski Pregled 31(9-10): 403-408
Gupta, P.; Jadaun, G.P.S.; Das, R.; Gupta, U.D.; Srivastava, K.; Chauhan, A.; Sharma, V.D.; Chauhan, D.S.; Katoch, V.M. 2006: Simultaneous ethambutol and isoniazid resistance in clinical isolates of Mycobacterium tuberculosis Indian Journal of Medical Research 123(2): 125-130
Chierakul, N.; Saengthongpinij, V.; Foongladda, S. 2014: Clinical features and outcomes of isoniazid mono-resistant pulmonary tuberculosis Journal of the Medical Association of Thailand 97(Suppl 3): S86-S90
Bristow, C.C.; Larson, E.; Vilakazi-Nhlapo, A.K.; Wilson, M.; Klausner, J.D. 2012: Scale-up of isoniazid preventive therapy in PEPFAR-assisted clinical sites in South Africa International Journal of Tuberculosis and Lung Disease: the Official Journal of the International Union Against Tuberculosis and Lung Disease 16(8): 1020-1022
Leperchey, F.; Vivien, J.N.; Vicaut, E.; Galliot, M.; Deplus, S.; Gervais, P. 1985: Power of isoniazid acetylation and pigmentation; first experimental tests in the rabbit: comparison with clinical data International Journal of Clinical Pharmacology Research 5(4): 283-286
Brandão, F.; Polónia, J. 1992: Clinical trials in cardiovascular clinical pharmacology Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 11(3): 273-281
Ahmad, B.; Idrees, M.; Ahmad, K.; Bashir, S.; Jamil, S. 2017: Molecular characterisation of isoniazid resistant clinical isolates of Mycobacterium tuberculosis from Khyber Pakhtunkhwa, Pakistan Jpma. Journal of the Pakistan Medical Association 67(8): 1224-1227
Coban, A.Y.; Bilgin, K.; Uzun, M.; Durupinar, B. 2009: Effect of linezolid in combination with isoniazid and rifampicin against multidrug resistant Mycobacterium tuberculosis clinical isolates Mikrobiyoloji Bulteni 43(2): 293-297